Literature DB >> 32713281

The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19.

Senthil Selvaraj1, Stephen J Greene2, Sameed Ahmed M Khatana1, Ashwin S Nathan1, Scott D Solomon3, Deepak L Bhatt4.   

Abstract

Entities:  

Keywords:  COVID‐19; biomarker; clinical trial; renin-angiotensin system; troponin

Mesh：

Year:  2020        PMID： 32713281     DOI： 10.1161/JAHA.120.018274

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN： 2047-9980            Impact factor:   5.501


× No keyword cloud information.
  5 in total

1.  The ongoing impact of COVID-19 on cardiovascular care.

Authors:  Mark Nicholls
Journal:  Eur Heart J       Date:  2021-05-08       Impact factor: 29.983

Review 2.  Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.

Authors:  Azita H Talasaz; Parham Sadeghipour; Hessam Kakavand; Maryam Aghakouchakzadeh; Elaheh Kordzadeh-Kermani; Benjamin W Van Tassell; Azin Gheymati; Hamid Ariannejad; Seyed Hossein Hosseini; Sepehr Jamalkhani; Michelle Sholzberg; Manuel Monreal; David Jimenez; Gregory Piazza; Sahil A Parikh; Ajay J Kirtane; John W Eikelboom; Jean M Connors; Beverley J Hunt; Stavros V Konstantinides; Mary Cushman; Jeffrey I Weitz; Gregg W Stone; Harlan M Krumholz; Gregory Y H Lip; Samuel Z Goldhaber; Behnood Bikdeli
Journal:  J Am Coll Cardiol       Date:  2021-03-11       Impact factor: 24.094

Review 3.  Cardiac involvement in the long-term implications of COVID-19.

Authors:  Benjamin A Satterfield; Deepak L Bhatt; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2021-10-22       Impact factor: 49.421

4.  Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials.

Authors:  Katia Audisio; Hillary Lia; Newell Bryce Robinson; Mohamed Rahouma; Giovanni Soletti; Gianmarco Cancelli; Roberto Perezgrovas Olaria; David Chadow; Derrick Y Tam; Dominique Vervoort; Michael E Farkouh; Deepak L Bhatt; Stephen E Fremes; Mario Gaudino
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-10

5.  The COVID-19 pandemic: a catalyst to improve clinical trials.

Authors:  Prakriti Gaba; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2020-11       Impact factor: 32.419
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.